TPI
SUPN icon

Trust Point Inc’s Supernus Pharmaceuticals SUPN Stock Holding History

Trust Point Inc’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-8,521
Closed -$308K – 552
2024
Q4 		$308K Sell
8,521
-7,812
-48% -$275K 0.02% 416
2024
Q3 		$509K Buy
16,333
+92
+0.6% +$2.87K 0.04% 277
2024
Q2 		$434K Sell
16,241
-3
-0% -$87 0.03% 294
2024
Q1 		$554K Buy
16,244
+5,020
+45% +$149K 0.04% 267
2023
Q4 		$325K Buy
+11,224
New +$298K 0.03% 381

Other funds holding SUPN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

Trust Point Inc's SUPN Position: Q1 2025 in Review

Trust Point Inc sold out of Supernus Pharmaceuticals (SUPN) in Q1 2025, closing a stake of 8,521 shares — an estimated $308K sold.

Trust Point Inc first reported a position in SUPN in Q4 2023 and held it in 5 quarters. The position peaked at $554K in Q1 2024. 295 funds tracked by Wall St. Rank hold SUPN as of Q1 2025.

  • Trust Point Inc reported no remaining Supernus Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • Trust Point Inc sold 8,521 Supernus Pharmaceuticals shares in Q1 2025, an estimated $308K.
  • Trust Point Inc first reported a position in Supernus Pharmaceuticals in Q4 2023 and held it in 5 quarters.
  • Trust Point Inc's Supernus Pharmaceuticals position peaked at $554K in Q1 2024.
  • 295 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q1 2025.

Based on Trust Point Inc's 13F filing for Q1 2025, filed 17 Apr 2025.